DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Marx N, Froehlich J, Siam L et al.
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
Arterioscler Thromb Vasc Biol 2003;
23: 283-288
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.